Evaluating Organ Systems in Lupus
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
Anifrolumab for Lupus
Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.
When the Patient Insists on Natural Therapies
Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.
Encouraging Medical Students to Choose Rheumatology
Facing a growing shortage, rheumatology is looking to attract the next generation of providers.
International Medical School Students Filling the Rheumatologist Shortage
Retaining international medical students, addressing student loan debt, mentoring and case-based teaching could possibly reverse the rheumatologist shortage, analysis says.
Q&A: Periodontal Disease and Rheumatoid Arthritis
In this Q&A we feature a conversation with Felipe Andrade, M.D., Ph.D., of the Johns Hopkins University School of Medicine in Baltimore.
PsA Treatment Guidelines Organized by Five Domains
The 2015 recommendations for PsA treatment highlight the importance of managing comorbidities and a patient-centered treatment approach.
Predictive Modeling for Spine Surgeries in the MACRA Era
Predictive modeling data can steer physicians toward making healthcare decisions that have positive outcomes for patients.
How Should CVD Risk be Assessed in Rheumatoid Arthritis?
Q&A: Two experts discuss proposals for formal CVD risk calculators in RA and the need for long-term research to validate them.
Breaking Down Quality Indicators in Post-Op Rehab and PT
Identifying quality indicators will be important under MACRA. Some say quality indicators are true measurements that reflect the standard of care.